Back to Verition Fund Management LLC Verition Fund Management LLC

KNSA

6 quarters

Position history for Verition Fund Management LLCVerition Fund Management LLC's holdings in Kiniksa Pharmaceuticals International, plc

Yes. Verition holds 7,500 shares of KNSA (Kiniksa Pharmaceuticals International), worth $479,625, as of its Q2 2026 13F filing. It opened the position in Q2 2026.

Current Value

$479,625

Current Shares

7,500

Total Value Change

-$189,707

Total Shares Change

-19,284

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
7,500
-
$479,6250.0%$63.95
33
2025-Q3
Exited
0
-100.0%
$00.0%$38.83
0
2025-Q2
Decreased
21,368
-23.7%
$591,2530.0%$27.67
0
2025-Q1
Decreased
27,993
-48.9%
$621,7250.0%$22.21
0
2024-Q4
Increased
54,728
+104.3%
$1.1M0.0%$19.78
41
2024-Q3
New
26,784
-
$669,3320.0%$24.99
34

Other major holders of KNSA: FMR LLC, Baker Bros. Advisors LP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used